Skip to main content
. 2025 May 28;84:103256. doi: 10.1016/j.eclinm.2025.103256

Table 1.

Conceptual mapping of the shortlisted PRO measures to the symptom Burden domain of the ePRO conceptual framework.

Sub-domain FACT (BMT) MDASI-CAR QoL-BMT SBQ
Neurological symptoms (n = 17) 2 6 2 8
Skin and hair-related symptoms (n = 8) 0 0 0 4
Ear, nose and throat (n = 10) 1 1 3 5
Clinical signs (n = 9) 1 4 1 6
Cardiopulmonary (n = 4) 1 1 1 1
Psychological (n = 8) 1 2 4 3
Gastrointestinal (n = 6) 1 3 2 6
Fever-related symptoms (n = 3) 0 1 0 3
Infection (n = 5) 1 0 0 1
Sleep (n = 5) 2 2 1 3
Musculoskeletal (n = 4) 0 0 0 3
Sexual functioning (n = 3) 1 1 2 2
Fatigue (n = 3) 1 1 1 1
Vision/eye-related symptoms (n = 3) 1 0 1 2
Interference (n = 7) 5 6 6 6
Total symptom concepts (N = 95) 18 28 24 54
Sub-domains represented (15/15) (%) 12 (80%) 11 (73%) 11 (73%) 15 (100%)

FACT (BMT), Functional Assessment of Cancer Therapy–Bone Marrow Transplant; MDASI-CAR, MD Anderson Symptom Inventory CAR module; QoL-BMT, Quality of Life Bone Marrow Transplant Survivors; SBQ Symptom Burden Questionnaire.